Management of Cough in Children Under 5 with Possible Asthma or Recurrent Wheezing
For a child under 5 with cough and risk factors for asthma (such as recurrent wheezing, eczema, or family history), initiate a 2-4 week trial of inhaled corticosteroids at 400 mcg/day beclomethasone equivalent, with mandatory reassessment to determine response and avoid overdiagnosis. 1
Initial Assessment: Distinguish Non-Specific from Specific Cough
Determine if the cough is "non-specific" (dry cough without other respiratory findings) or "specific" (wet/productive cough or accompanied by other concerning features). 1
- Non-specific cough presents as isolated dry cough without abnormal chest examination, normal chest X-ray (if obtained), and no systemic symptoms 1
- Specific cough includes wet/productive cough, abnormal examination findings, or associated symptoms suggesting underlying pulmonary disease 1
- Most post-viral coughs in children resolve spontaneously within 2-4 weeks, with 90% of viral bronchiolitis cases cough-free by day 21 2
Critical Diagnostic Principle: Avoid Asthma Overdiagnosis
Do NOT diagnose asthma based on cough alone without documented wheezing—children with chronic cough as the only symptom are unlikely to have asthma. 2, 3, 4
- The European Respiratory Society strongly recommends against diagnosing asthma on symptoms alone, even when classic features are present 3, 4
- Recurrent wheezing (not isolated cough) is the most important symptom of asthma 2, 4
- Cough variant asthma is "probably a misnomer for most children in the community who have persistent cough" 3
- Only 3 of 23 children with isolated chronic cough showed asthma-type airway inflammation in research studies 3
When to Consider a Trial of Asthma Therapy
Initiate inhaled corticosteroids ONLY when specific risk factors for asthma are present: 1
- Recurrent wheezing (more than 3 episodes in the previous year) 2
- Atopic features: eczema, food allergies 2, 3
- Family history of asthma 2
- Variable symptoms that change in intensity over time 2
Specific Treatment Protocol for Trial Therapy
If asthma risk factors are present, use the following structured approach: 1
- Dose: 400 mcg/day beclomethasone or budesonide equivalent (this dose is effective for most childhood asthma and minimizes adverse effects at higher doses) 1
- Duration: 2-4 weeks initially 1
- Reassessment is mandatory: Evaluate response at 2-4 weeks 1
- If no response: STOP the inhaled corticosteroid—do not increase the dose 1
- If cough resolves: Re-evaluate the child OFF treatment, as resolution may be due to spontaneous improvement (period effect) rather than true asthma 1
Critical Pitfall: The "Period Effect"
Be aware that cough resolution during treatment may represent natural resolution rather than treatment response. 1
- Many post-viral coughs resolve spontaneously within the 2-4 week timeframe of a therapeutic trial 1, 2
- If cough resolved with inhaled corticosteroids, the child does not necessarily have asthma 1
- A proper therapeutic trial requires: clear response to treatment, relapse upon stopping, and second response when restarted 3
What NOT to Use in Children Under 5
Avoid over-the-counter cough medications—they lack efficacy and carry potential morbidity and mortality risks. 1
- The FDA issued warnings against OTC cough medications in children under 4 years of age 1
- Systematic reviews conclude OTC cough medications have little to no benefit for symptomatic control in children 1
- Oral steroids are NOT recommended: One RCT in children aged 1-5 years with wheeze (without asthma) found oral steroids provided no benefit and were associated with increased hospitalizations 1
- Dexamethasone provides no benefit for pertussis-associated cough 1
Alternative Diagnoses to Consider in This Age Group
If cough persists beyond 4 weeks or fails to respond to asthma therapy, consider: 1, 5
- Protracted bacterial bronchitis (PBB): Presents with wet/productive cough, treat with 2 weeks of antibiotics, repeat if wet cough persists 1, 6
- Post-infectious cough: Common after viral illnesses, typically resolves spontaneously 5
- Foreign body aspiration: Especially with sudden onset cough 5
- Tracheobronchomalacia: Consider if barking or brassy cough 1, 5
- Gastroesophageal reflux disease: Less common in this age group 5
Structured Follow-Up Algorithm
For non-specific cough without asthma risk factors: 1
- Watch, wait, and review approach 1
- Re-evaluate in 2-4 weeks for emergence of specific etiological pointers 1
- Most cases resolve spontaneously 1, 2
For children started on inhaled corticosteroids: 1
- Mandatory reassessment at 2-4 weeks 1
- If no improvement: STOP treatment and investigate other causes 1
- If improvement: Trial off medication to confirm diagnosis 1
- If symptoms recur off treatment and respond again when restarted, asthma diagnosis is more secure 3
Key Environmental and Supportive Measures
Evaluate and address environmental factors at every visit: 1